Late-breaking trials and trial updates

Session comprising selected EuroPCR 2017 late-breaking trial submissions

Chairpersons: D. Capodanno, W. Wijns

Presentations available when logged in:

  • Benefit of evolutive dual antiplatelet therapy after acute coronary syndromes: the TOPIC trial
  • DESSOLVE III, a randomised comparison of Xience vs MiStent, a novel DES that embeds sirolimus microcrystals in the vessel wall
  • Safety of coronary revascularisation deferral based on iFR and FFR measurements in stable angina and acute coronary syndromes: a pooled patient-lev...
  • A prospective, randomised investigation of a novel TAVI system: the REPRISE III trial